Actively Recruiting
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
Led by Eli Lilly and Company · Updated on 2025-11-03
7000
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to measure the difference in the proportion of participants with prespecified patient management actions between a tested interventional group and a control group.
CONDITIONS
Official Title
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Primary care physicians who routinely evaluate patients over age 50 in family or internal medicine
- Secondary or tertiary care physicians experienced in diagnosing and treating cognitive impairment and dementia
- HCPs in the interventional group willing to review educational materials before enrolling patients
- Patients capable of giving informed consent
- Patients with sufficient venous access for blood sampling
- Patients willing and able to follow study procedures
- Patients presenting with one or more subjective cognitive impairment complaints within 4 weeks before identification
You will not qualify if you...
- Patients with prior or associated HCP-ordered referrals or drug therapies for cognitive complaints in the past 18 months
- Patients with prior amyloid or tau biomarker tests including PET scans, CSF tests, or blood tests
- Patients with serious or unstable illnesses likely to interfere with study completion or life expectancy under 1 year
- Patients with known brain lesions, pathologies, or alternative diagnoses explaining cognitive symptoms
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SiteRx Virtual Site
New York, New York, United States, 10013
Actively Recruiting
Research Team
T
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
CONTACT
P
Physicians interested in becoming principal investigators please contact
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here